Insider Transactions Reported by 22 Insiders of Vaxcyte, Inc.

Symbol: PCVX on Nasdaq
Location: San Carlos, CA

Quick Takeaways

PCVX - Vaxcyte, Inc. has 22 insiders with reported activity on this page.
Net insider value flow over the last year: -$2,010,407.
Recent transaction rows are available for direct filing-level review.

What Changed

Buy value: ; sell value: $2,010,407.
Net share flow: -38,403.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$2,010,407.

Buys

Shares: 0

Insiders: 0

Sells

$2,010,407

Shares: 38,403

Insiders: 3

Net

-$2,010,407

Shares: -38,403

Insiders: -3

Window (months)	Sell shares	Buy $	Sell $	Net $
0-3	17,037	$0	$998,544	-$998,544
3-6	21,366	$0	$1,011,863	-$1,011,863
6-9	0	$0	$0	$0
9-12	0	$0	$0	$0

Vaxcyte, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
Grant Pickering	CHIEF EXECUTIVE OFFICER, Director	$35,551,596			Mixed	09 Mar 2026
Jeff Fairman	VP, Research	$22,935,618			Mixed	30 Dec 2022
Jim Wassil	Chief Operating Officer	$9,605,562	-$566,916	-5.6%	Filing P/S	01 Apr 2026
Andrew Guggenhime	President And Cfo	$9,334,656			Mixed	09 Mar 2026
Harpreet S. Dhaliwal	Chief Technical Ops Officer	$4,266,052	-$454,891	-9.6%	Mixed	09 Mar 2026
Mikhail Eydelman	Svp, Gen Counsel & Corp Sec	$3,012,039			Filing P/S	05 Mar 2025
Elvia Cowan	SVP, Finance & CAO	$1,738,500	-$988,601	-36%	Filing P/S	07 Apr 2026
Peter Hirth	Director	$1,043,024			Mixed	06 Jun 2024
Halley E. Gilbert	Director	$742,052			Mixed	12 Jun 2025
Heath Lukatch	Director	$499,264			Mixed	12 Jun 2025
Michael E. Kamarck	Director	$364,388			Mixed	13 Jun 2023
Teri Loxam	Director	$296,264			Mixed	12 Jun 2025
Anne S. Drapeau	Director	$296,264			Mixed	12 Jun 2025
Carlos Paya V	Director	$296,264			Mixed	12 Jun 2025
Jane Wright-Mitchell	General Counsel	$202,438			Mixed	16 Aug 2021
Jacks Lee	Director	$133,139			Mixed	12 Jun 2025
Olivier Brandicourt	Director	$115,580			Mixed	15 Jan 2026
John Furey	Director	$88,189			Mixed	12 Jun 2025
Paul Sauer	SVP Process Dev, Manufacturing				Mixed	30 Dec 2022
Emster Kurt von	Director				Mixed	02 Jun 2021
Patrick J. Heron	Director				Mixed	02 Jun 2021
Robert Lorne Hopfner	Director				Mixed	02 Jun 2021

Top shareholders of Vaxcyte, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F 13D/G	Company	10% from 13D/G	13,834,514	$638,324,485	—	31 Dec 2025	13F 13D/G
JANUS HENDERSON GROUP PLC	13F 13D/G	Company	10% from 13D/G	13,387,188	$617,730,753	—	31 Dec 2025	13F 13D/G
VANGUARD GROUP INC	13F	Company	9.3%	12,193,986	$562,630,515	—	31 Dec 2025	13F
T. Rowe Price Investment Management, Inc.	13F 13D/G	Company	8.6% from 13D/G	11,296,333	$521,213,000	—	31 Dec 2025	13F 13D/G
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G	Company	9.9% from 13D/G	10,724,599	$494,832,998	—	31 Dec 2025	13F 13D/G
BlackRock, Inc.	13F 13D/G	Company	7.6% from 13D/G	10,246,378	$472,767,877	—	31 Dec 2025	13F 13D/G
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4.5%	5,966,310	$275,285,543	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	3.8%	4,980,005	$229,777,431	—	31 Dec 2025	13F
Paradigm Biocapital Advisors LP	13F	Company	3.1%	4,068,020	$187,698,443	—	31 Dec 2025	13F
Deep Track Capital, LP	13F	Company	3%	4,000,000	$184,560,000	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	2.8%	3,631,053	$167,536,785	—	31 Dec 2025	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	2.7%	3,539,717	$163,322,542	—	31 Dec 2025	13F
Kynam Capital Management, LP	13F	Company	2.2%	2,922,335	$134,836,537	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	2,866,305	$132,271,037	—	31 Dec 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.3%	1,725,000	$79,591,500	—	31 Dec 2025	13F
Caligan Partners LP	13F	Company	1.3%	1,704,815	$78,660,164	—	31 Dec 2025	13F
Polar Capital Holdings Plc	13F	Company	1.3%	1,672,783	$77,182,208	—	31 Dec 2025	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	1%	1,372,425	$63,323,690	—	31 Dec 2025	13F
MAVERICK CAPITAL LTD	13F	Company	1%	1,354,237	$62,484,495	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.99%	1,293,830	$59,697,316	—	31 Dec 2025	13F
NORGES BANK	13F	Company	0.94%	1,228,939	$56,703,245	—	31 Dec 2025	13F
Eversept Partners, LP	13F	Company	0.91%	1,197,722	$55,262,893	—	31 Dec 2025	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.89%	1,175,339	$54,232,000	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.83%	1,093,593	$50,458,382	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.83%	1,085,519	$50,085,850	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.82%	1,078,120	$49,744,457	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.79%	1,034,180	$47,717,065	—	31 Dec 2025	13F
Aberdeen Group plc	13F	Company	0.75%	979,765	$45,206,357	—	31 Dec 2025	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.7%	917,115	$42,312,560	—	31 Dec 2025	13F
Novo Holdings A/S	13F	Company	0.7%	916,160	$42,271,622	—	31 Dec 2025	13F
Pictet Asset Management Holding SA	13F	Company	0.67%	881,435	$40,669,411	—	31 Dec 2025	13F
Capital Research Global Investors	13F	Company	0.64%	842,978	$38,895,005	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.64%	835,387	$38,544,817	—	31 Dec 2025	13F
Saturn V Capital Management LP	13F	Company	0.61%	798,940	$36,863,092	—	31 Dec 2025	13F
Grant Pickering	3/4/5	CHIEF EXECUTIVE OFFICER, Director	— mixed-class rows	808,852 mixed-class rows	$35,551,596	—	09 Mar 2026	3/4/5
Trails Edge Capital Partners, LP	13F	Company	0.56%	737,470	$34,026,866	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.53%	701,634	$32,373,393	—	31 Dec 2025	13F
JENNISON ASSOCIATES LLC	13F	Company	0.52%	677,553	$31,262,296	—	31 Dec 2025	13F
Logos Global Management LP	13F	Company	0.49%	650,000	$29,991,000	—	31 Dec 2025	13F
Soleus Capital Management, L.P.	13F	Company	0.46%	608,958	$28,097,322	—	31 Dec 2025	13F
BROWN ADVISORY INC	13F	Company	0.43%	566,925	$26,157,919	—	31 Dec 2025	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.42%	549,514	$25,354,577	—	31 Dec 2025	13F
Assenagon Asset Management S.A.	13F	Company	0.41%	544,728	$25,133,750	—	31 Dec 2025	13F
Ensign Peak Advisors, Inc	13F	Company	0.4%	527,688	$24,347,524	—	31 Dec 2025	13F
FEDERATED HERMES, INC.	13F	Company	0.4%	523,489	$24,153,783	—	31 Dec 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.38%	497,740	$22,965,724	—	31 Dec 2025	13F
Jeff Fairman	3/4/5	VP, Research	— mixed-class rows	369,054 mixed-class rows	$22,935,618	—	30 Dec 2022	3/4/5
EcoR1 Capital, LLC	13F	Company	0.34%	450,000	$20,763,000	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.34%	449,363	$20,733,624	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.32%	424,294	$19,576,925	—	31 Dec 2025	13F

Recent Insider Transactions by Companies or Individuals for Vaxcyte, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Elvia Cowan	PCVX	Common Stock	Sale	-9.38%	$180,000	$60.00	-3,000	28,975	07 Apr 2026	Direct
Elvia Cowan	PCVX	Common Stock	Options Exercise	10.4%			3,000	31,975	07 Apr 2026	Direct
Elvia Cowan	PCVX	Stock Option (right to buy)	Options Exercise	-3.12%			-3,000	93,068	07 Apr 2026	Direct
Jim Wassil	PCVX	Common Stock	Sale	-1.36%	$131,476	$58.43	-2,250	162,994	01 Apr 2026	Direct
Elvia Cowan	PCVX	Common Stock	Sale	-6.13%	$105,147	$55.57	-1,892	28,975	17 Mar 2026	Direct
Elvia Cowan	PCVX	Common Stock	Sale	-7.49%	$146,482	$58.59	-2,500	30,867	11 Mar 2026	Direct
Elvia Cowan	PCVX	Common Stock	Options Exercise	8.1%			2,500	33,367	11 Mar 2026	Direct
Elvia Cowan	PCVX	Stock Option (right to buy)	Options Exercise	-2.54%			-2,500	96,068	11 Mar 2026	Direct
Jim Wassil	PCVX	Common Stock	Sale	-4.24%	$435,440	$58.88	-7,395	166,818	10 Mar 2026	Direct
Grant Pickering	PCVX	Common Stock	Tax liability	-0.74%			-3,685	496,939	09 Mar 2026	Direct
Andrew Guggenhime	PCVX	Common Stock	Tax liability	-0.97%			-1,021	104,395	09 Mar 2026	Direct
Elvia Cowan	PCVX	Common Stock	Tax liability	-1.58%			-495	30,867	09 Mar 2026	Direct
Jim Wassil	PCVX	Common Stock	Tax liability	-0.56%			-975	174,213	09 Mar 2026	Direct
Harpreet S. Dhaliwal	PCVX	Common Stock	Tax liability	-0.79%			-604	75,976	09 Mar 2026	Direct
Elvia Cowan	PCVX	Common Stock	Tax liability	-1.03%			-326	31,362	02 Mar 2026	Direct
Andrew Guggenhime	PCVX	Common Stock	Tax liability	-0.95%			-1,009	105,416	02 Mar 2026	Direct
Grant Pickering	PCVX	Common Stock	Tax liability	-0.5%			-2,531	500,624	02 Mar 2026	Direct
Harpreet S. Dhaliwal	PCVX	Common Stock	Tax liability	-0.6%			-465	76,580	02 Mar 2026	Direct
Jim Wassil	PCVX	Common Stock	Tax liability	-0.57%			-1,009	175,188	02 Mar 2026	Direct
Elvia Cowan	PCVX	Common Stock	Tax liability	-0.76%			-243	31,688	28 Feb 2026	Direct
Andrew Guggenhime	PCVX	Common Stock	Tax liability	-0.84%			-898	106,425	28 Feb 2026	Direct
Grant Pickering	PCVX	Common Stock	Tax liability	-0.57%			-2,863	503,155	28 Feb 2026	Direct
Harpreet S. Dhaliwal	PCVX	Common Stock	Tax liability	-0.38%			-292	77,045	28 Feb 2026	Direct
Jim Wassil	PCVX	Common Stock	Tax liability	-0.51%			-898	176,197	28 Feb 2026	Direct
Jim Wassil	PCVX	Common Stock	Tax liability	-1.06%			-1,900	177,095	27 Feb 2026	Direct
Jim Wassil	PCVX	Common Stock	Award	2.93%			5,102	178,995	27 Feb 2026	Direct
Elvia Cowan	PCVX	Common Stock	Options Exercise	31.9%			7,716	31,931	26 Feb 2026	Direct
Elvia Cowan	PCVX	Common Stock	Award	78.9%			10,681	24,215	26 Feb 2026	Direct
Elvia Cowan	PCVX	Stock Option (right to buy)	Options Exercise	-7.26%			-7,716	98,568	26 Feb 2026	Direct
Elvia Cowan	PCVX	Stock Option (right to buy)	Award				17,855	17,855	26 Feb 2026	Direct
Andrew Guggenhime	PCVX	Common Stock	Award	71.8%			44,864	107,323	26 Feb 2026	Direct
Andrew Guggenhime	PCVX	Stock Option (right to buy)	Award				74,993	74,993	26 Feb 2026	Direct
Grant Pickering	PCVX	Common Stock	Award	26.2%			105,110	506,018	26 Feb 2026	Direct
Grant Pickering	PCVX	Stock Option (right to buy)	Award				175,698	175,698	26 Feb 2026	Direct
Harpreet S. Dhaliwal	PCVX	Common Stock	Award	223.2%			53,409	77,337	26 Feb 2026	Direct
Harpreet S. Dhaliwal	PCVX	Stock Option (right to buy)	Award				46,424	46,424	26 Feb 2026	Direct
Jim Wassil	PCVX	Common Stock	Award	22.6%			32,045	173,893	26 Feb 2026	Direct
Jim Wassil	PCVX	Stock Option (right to buy)	Award				53,566	53,566	26 Feb 2026	Direct
Olivier Brandicourt	PCVX	Common Stock	Award	118.2%			1,357	2,505	15 Jan 2026	Direct
Olivier Brandicourt	PCVX	Stock Option (right to buy)	Award				6,750	6,750	15 Jan 2026	Direct
Grant Pickering	PCVX	Common Stock	Gift	-20%			-100,000	400,908	14 Jan 2026	Direct
Andrew Guggenhime	PCVX	Common Stock	Gift				61,850	61,850	14 Jan 2026	See Footnote
Andrew Guggenhime	PCVX	Common Stock	Gift	-49.8%			-61,850	62,459	14 Jan 2026	Direct
Harpreet S. Dhaliwal	PCVX	Common Stock	Sale	-28.9%	$454,891	$46.69	-9,743	23,928	31 Dec 2025	Direct
Elvia Cowan	PCVX	Common Stock	Gift	-6.88%			-1,000	13,534	23 Dec 2025	Direct
Elvia Cowan	PCVX	Common Stock	Sale	-44.4%	$556,972	$47.92	-11,623	14,534	23 Dec 2025	Direct
Elvia Cowan	PCVX	Common Stock	Tax liability	-1.81%			-482	26,156	08 Sep 2025	Direct
Harpreet S. Dhaliwal	PCVX	Common Stock	Tax liability	-3.45%			-1,204	33,670	08 Sep 2025	Direct
Jim Wassil	PCVX	Common Stock	Tax liability	-1.91%			-2,759	141,848	08 Sep 2025	Direct
Andrew Guggenhime	PCVX	Common Stock	Tax liability	-2.27%			-2,890	124,309	08 Sep 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.